Highlights: Xu Jinghe, Deputy Director of the National Food and Drug Administration, investigates Tupai |, a national-level "Little giant" company. Tupai was listed on | and Tupai was listed on Fortune's China list

Highlight continues: Xu Jinghe, Deputy Director of the National Medical Products Administration, conducted research on Tu Pai | National "Little Giant" unveiled, Tu Pai selected | Tu Pai shortlisted for Fortune China list
 

On August 23rd, Xu Jinghe, a member of the Party Group and Deputy Director of the National Medical Products Administration, conducted research in Beijing and visited Beijing Pinchi Medical Equipment Co., Ltd., Tupai (Beijing) Medical Technology Co., Ltd., Medda (Beijing) Medical Equipment Co., Ltd., and Changping Life Valley Industrial Base. He also held a symposium in Changping to gain a deeper understanding of the innovative and high-quality development needs of the medical device industry and the work of product quality supervision.

Xu Jinghe visited the production line of Tupai Medical's Beijing production base in detail and affirmed the technical achievements of Tupai Medical's ophthalmic OCT and other products. He had in-depth exchanges with Tupai Medical's management team. Xu Jinghe gave instructions for enterprises to further improve the quality and safety responsibility system of medical devices, comprehensively strengthen the quality supervision of the entire life cycle of medical devices, and put forward valuable suggestions such as the digital and intelligent transformation of assembly and adjustment production lines.

Sun Liguang, Secretary of the Party Group of the Beijing Food and Drug Administration, and Gan Jingzhong, Secretary of the Changping District Committee of Beijing, along with other city and district leaders, jointly participated in this research visit.

Please refer to the official report for details

https://www.nmpa.gov.cn/yaowen/ypjgyw/ylqxyw/20240823175830103.html?type=pc&m=

On September 2nd, the results of the sixth batch of national level "specialized, refined, unique and new" small giant enterprises were announced, and Tupai Medical was successfully awarded.

According to the recognition standards of the Ministry of Industry and Information Technology, national level specialized, refined, and innovative "little giant" enterprises are outstanding among specialized, refined, innovative, and innovative enterprises. They are industry-leading enterprises that focus on segmented markets, have strong innovation capabilities, high market share, master key core technologies, and excellent quality and efficiency.

Therefore, the title of "Little Giant" at the national level is the highest level, most innovative, and authoritative honor for specialized, refined, and innovative enterprises. This award of the national level specialized and innovative "Little Giant" enterprise is a full recognition of Tupai Medical's independent innovation strength and leading position in the industry by government departments and industry experts.

Please refer to the official report for details

https://m.peopledailyhealth.com/articleDetailShare?articleId=76c8a64b45a8417dba20643ed882fe1f

On September 11th, Fortune China's most socially influential startup company was announced, and Tupai Medical was shortlisted.

The original intention of producing the list of China's most influential start-up companies by Fortune is to examine the most active and dynamic business entities in the Chinese economy, and select typical enterprises that can represent the characteristics of China's economic development.

Please refer to the official report for details

https://www.fortunechina.com/impact/2024.htm?_refluxos=a10